Brachial arterial pressure to assess cardiovascular structural damage: An overview and lessons from clinical trials

Journal of Nephrology

Volumn 21, Issue 1, 2008, Pages 23-31

  London, Gérard M ^a  

^a Manhes Hospital   (France)

Author keywords

Aortic pressure; Arterial stiffness; Brachial pressure; Wave reflections

Indexed keywords

AMLODIPINE; ATENOLOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; INDAPAMIDE; NITRIC ACID DERIVATIVE; PERINDOPRIL; THIAZIDE DIURETIC AGENT;

AORTA PRESSURE; ARTERIAL PRESSURE; ARTERIAL STIFFNESS; BLOOD PRESSURE REGULATION; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; DIASTOLIC BLOOD PRESSURE; DISEASE ASSOCIATION; DISEASE SEVERITY; DRUG EFFICACY; DRUG INDICATION; DRUG MECHANISM; DRUG RESPONSE; HEART LEFT VENTRICLE HYPERTROPHY; HUMAN; HYPERTENSION; INCIDENCE; KIDNEY FAILURE; MONOTHERAPY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTION; PULSE PRESSURE; REMISSION; REVIEW; SYSTOLIC BLOOD PRESSURE; AORTA; BLOOD PRESSURE; BLOOD PRESSURE MEASUREMENT; PATHOPHYSIOLOGY; PHYSIOLOGY;

AORTA; BLOOD PRESSURE; BLOOD PRESSURE DETERMINATION; BRACHIAL ARTERY; CARDIOVASCULAR DISEASES; CLINICAL TRIALS AS TOPIC; HUMANS; HYPERTENSION;

EID: 43249114415     PISSN: 11218428     EISSN: 17246059     Source Type: Journal    
DOI: None     Document Type: Review

References (53)

1. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;24:1571-1576.
2. Franklin SS, Gustin W, Wong ND, et al. Hemodynamic patterns of age-related changes in blood pressure. Circulation. 1997;96:308-15.
3. Black HR. The paradigm has shifted to systolic blood pressure. Hypertension. 1999;34:386-387.
4. Izzo JL, Levy D, Black HR. Importance of systolic blood pressure in older Americans. Hypertension. 2000;35:1021-1024.
5. Franklin SS, Jacobs MJ, Wong ND, L'Italien GJ, Lapuerta P. Predominance of isolated systolic hypertension among middle-aged and elderly US hypertensives: analysis based on National Health and Nutrition Examination Survey (NHANES) III. Hypertension. 2001;37:869-874.
6. Benetos A, Rudnichi A, Safar M, Guize L. Pulse pressure and cardiovascular mortality in normotensive and hypertensive subjects. Hypertension. 1998;32:560-564.
7. Blacher J, Staessen JA, Girerd X, et al. Pulse pressure not mean pressure determines cardiovascular risk in older hypertensive patients. Arch Intern Med. 2000;160:1085-1089.
8. Franklin SS, Khan SA, Wong ND, Larson MG, Levy D. Is pulse pressure useful in predicting risk for coronary heart disease? The Framingham Heart Study. Circulation. 1999;100:354-360.
9. Franklin SS, Larson MG, Khan SA, et al. Does the relation of blood pressure to coronary heart disease risk change with aging? The Framingham Heart Study. Circulation. 2001;103:1245-1249.
10. Staessen JA, Gasowski J, Wang JG, et al. Risks of untreated and treated isolated systolic hypertension in the elderly: meta-analysis of outcome trials. Lancet. 2000;355:865-872.
11. Lloyd-Jones DM, Evans JC, Larson MG, O'Donnell CJ, Roccella EJ, Levy D. Differential control of systolic and diastolic blood pressure: factors associated with lack of blood pressure control in the community. Hypertension. 2000;36:594-599.
12. Mourad J-J, Blacher J, Blin P, Warzocha U; PHASTE study. Conventional antihypertensive drug therapy does not prevent the increase of pulse pressure with age. Hypertension. 2001;38:958-962.
13. Krooker EJ, Wood EH. Comparison of simultaneously recorded central and peripheral arterial pressure pulses during rest, exercise and tilted position in man. Circ Res. 1955;3:623-632.
14. Karamanoglu M, O'Rourke MF, Avolio AP, Kelly RP. An analysis of the relationship between central aortic and peripheral upper limb pressure waves in man. Eur Heart J. 1993;14:160-167.
15. Kelly MP, Gibbs HH, O'Rourke M, et al. Nitroglycerine has more favorable effects on left ventricular afterload than is apparent from measurement of prssure in a peripheral artery. Eur Heart J. 1990;11:138-144.
16. Pannier BM, Guérin AP, Marchais SJ, London GM. Different aortic reflection wave responses following long-term angiotensin-converting enzyme inhibition and beta-blocker in hypertension. Clin Exp Pharmacol Physiol. 2001;28:1074-1077.
17. Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Coordinators and Investigators. Improvement in blood pressure, arterial stiffness and wave reflections with a very-low-dose perindopril/indapamide combination in hypertensive patients: a comparison with atenolol. Hypertension. 2001;38:922-926.
18. Morgan T, Lauri J, Bertram D, Anderson A. Effect of different antihypertensive drug classes on central aortic pressure. Am J Hypertens. 2004;17:118-123.
19. CAFÉ Investigators; for the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT) Investigators. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation. 2006;113:1213-1225.
20. Blacher J, Guérin AP, Pannier B, Marchais SJ, Safar ME, London GM. Impact of aortic stiffness on survival in endstage renal disease. Circulation. 1999;99:2434-2439.
21. Laurent S, Boutouyrie P, Asmar R, et al. Aortic stiffness is an independent predictor of all-cause and cardiovascular mortality in hypertensive patients. Hypertension. 2001;37:1236-1241.
22. Safar ME, London GM. The arterial system in human hypertension. In: Swales JD, ed. Textbook of Hypertension. London: Blackwell Scientific; 1994:85-102.
23. O'Rourke MF. Mechanical principles in arterial disease. Hypertension. 1995;26:2-9.
24. Antonios TF, Singer DR, Markandu ND, Mortimer PS, MacGregor GA. Structural skin capillary rarefaction in essential hypertension. Hypertension. 1999;33:998-1001.
25. Amann K, Breitbach M, Ritz E, Mall G. Myocyte/capillary mismatch in the heart of uremic patients. J Am Soc Nephrol. 1998;9:1018-1022.
26. Guyton AC, Hall JE, Jackson TE. The basic kidney-blood volume-pressure regulatory system: the pressure diuresis and natriuresis phenomena. In: Circulatory Physiology, III: Arterial Pressure and Hypertension. Philadelphia: Saunders; 1980:87-99.
27. Nichols WW, O'Rourke M. McDonald's Blood Flow in Arteries: Theoretical, Experimental and Clinical Principles. 4th ed. London: Edward Arnold; 1998:54-113, 201-222, 284-292, 347-401.
28. Izzo JL. Arterial stiffness and the systolic hypertension syndrome. Curr Opin Cardiol. 2004;19:341-352.
29. Murgo JP, Westerhof N, Giolma JP, Altobelli SA. Aortic input impedance in normal man: relationship to pressure wave forms. Circulation. 1980;62:105-116.
30. Latham RD, Westerhof N, Sipkema P, Rubal BJ, Reuderink P, Murgo JP. Regional wave travel and reflections along the human aorta: a study with six simultaneous micromanometric pressures. Circulation. 1985;72:1257-1269.
31. Avolio AO, Chen SG, Wang RP, Zhang CI, Li MF, O'Rourke MF. Effects of aging on changing arterial compliance and left ventricular load in a northern Chinese urban community. Circulation. 1983;68:50-58.
32. Nichols WW, Avolio AP, Kelly RP, O'Rourke MF. Effects of age and of hypertension on wave travel and reflections. In: O'Rourke M, Safar M, Dzau V, eds. Arterial Vasodilatation: Mechanisms and Therapy. London: Edward Arnold; 1993:23-40.
33. O'Rourke MF, Kelly RP. Wave reflections in systemic circulation and its implications in ventricular function. J Hypertens. 1993;11:327-337.
34. Chang KC, Tseng YZ, Kuo TS, Chen HI. Impaired left ventricular relaxation and arterial stiffness in patients with essential hypertension. Clin Sci. 1994;87:641-647.
35. Buckberg GD, Towers B, Paglia DE, Mulder DG, Maloney JV. Subendocardial ischemia after cardiopulmonary bypass. J Thorac Cardiovasc Surg. 1972;64:669-687.
36. Watanabe H, Ohtsuka S, Kakihana M, Sugishita Y. Coronary circulation in dogs with an experimental decrease in aortic compliance. J Am Coll Cardiol. 1993;21:1497-1506.
37. Blacher J, Pannier B, Guerin AP, Marchais SJ, Safar ME, London GM. Carotid arterial stiffness as a predictor of cardiovascular and all-cause mortality in end-stage renal disease. Hypertension. 1998;32:570-574.
38. Pannier B, Guérin AP, Marchais SJ, Safar ME, London GM. Stiffness of capacitive and conduit arteries: prognostic significance for end-stage renal disease patients. Hypertension. 2005;45:592-596.
39. Barenbrock M, Kosch M, Jöster E, Kisters K, Rahn KH, Hausberg M. Reduced arterial distensibility is a predictor of cardiovascular disease in patients after renal transplantation. J Hypertens. 2002;20:79-84.
40. Boutouyrie P, Tropeano AI, Asmar R, et al. Aortic stiffness is an independent predictor of primary coronary events in hypertensive patients: a longitudinal study. Hypertension. 2002;39:10-15.
41. Laurent S, Katsahian S, Fassot C, et al. Aortic stiffness is an independent predictor of fatal stroke in essential hypertension. Stroke. 2003;34:1203-1206.
42. Cruickshank K, Riste L, Anderson SG, Wright JS, Dunn G, Gosling RG. Aortic pulse-wave velocity and its relationship to mortality in diabetes and glucose intolerance: an integrated index of vascular function. Circulation. 2002;106:2085-2090.
43. London GM, Guérin AP, Marchais SJ, Pannier B, Safar ME, Day M. Cardiac and arterial interactions in end-stage renal disease. Kidney Int. 1996;50:600-608.
44. London GM, Guérin AP, Pannier B, Marchais SJ, Benetos A, Safar ME. Increased systolic pressure in chronic uremia: role of arterial wave reflections. Hypertension. 1992;20:10-19.
45. Safar ME, Blacher J, Pannier B, et al. Central pulse pressure and mortality in end-stage renal disease. Hypertension. 2002;39:735-738.
46. Roman MJ, Devereux RB, Kizer JR, et al. Central pressure more strongly relates to vascular disease and outcomes than brachial pressure: the Strong Heart Study. Hypertension. 2007;50:197-203.
47. London GM, Asmar RG, O'Rourke MF, Safar ME; on behalf of the REASON Project Investigators. Mechanisms of selective systolic blood pressure reduction after a low-dose combination of perindipril/indapamide in hypertensive subjects: comparison with atenolol. J Am Coll Cardiol. 2004;43:92-99.
48. de Luca N, Asmar RG, London GM, O'Rourke MF, Safar ME; REASON Project Investigators. Selective reduction of cardiac mass and central blood pressure on low-dose combination perindopril/indapamide in hypertensive subjects. J Hypertens. 2004;22:1623-1630.
49. Williams B, Lacy PS, Thorn SM, et al; CAFÉ Investigators; Anglo-Scandinavian Cardiac Outcomes Trial Investigators; CAFÉ steering Committee and Writing Committee. Differential impact of blood pressure-lowering drugs on central aortic pressure and clinical outcomes. Circulation. 2006;113:1213-1225.
50. Fitchett DH, Simkus GJ, Beaudry JP, Marpole DG. Reflected pressure waves in the ascending aorta: effect of glyceryl trinitrate. Cardiovasc Res. 1988;22:494-500.
51. Fitchett DH, Simkus GJ, Genest J, Marpole DG, Beaudry JP. Effect of nitroglycerin on left ventricular hydraulic load. Can J Cardiol. 1988;4:72-75.
52. London GM, Pannier B, Guerin AP, Marchais SJ, Safar ME, Cuche J. Cardiac hypertrophy, aortic compliance, peripheral resistance, and wave reflection in end-stage renal disease: comparative effects of ACE inhibition and calcium channel blockade. Circulation. 1994;90:2786-2796.
53. Ting CT, Chen JW, Chang MS, Yin FC. Arterial hemodynamics in human hypertension: effect of the calcium channel antagonist nifedipine. Hypertension. 1995;25:1326-1332.